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Abstract
Living related donors (LRD) have been the main source of donor kidneys in Hong Kong. In
recent years, there has been an increase in the proportion of cadaveric (CAD) kidneys transplan-
tation. This review examines the results of renal transplantation in. Queen Mary Hospital (QMH)
in order to assess the continuing need for LRD kidney transplantation. The records of 159 of 165
transplant cases between 1983 and 1991 were analyzed. The of recipients was 35.6 years
(range 11 to 57), with a male predominance in the LED recipients (p = 0.03). The waiting time for
the LRD recipients was significantly less than the CAD recipients (p < 0.001). There was no
difference in the distribution of different primary renal diseases causing end stage renal failure
between the LRD and CAD groups. The cumulative graft survival at five years was 82.5% and
65.8% for LRD and CAD respectively (p = 0.02), Graft function was also significantly better in
LRD recipients (p < 0,01), Early surgical complications more common after CAD transplan-
tation (14% vs 29%, p = 0.02). While the transplant centres and the Hong Kong Government
continue to promote cadaveric organ donation, the LRD transplant programme should be equally
encouraged because of superior graft outcome.
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Introduction.
Living related donors (LRD) have been the main
source of donor kidneys in Hong Kong until recently.
There has been a gradual increase in cadaveric (CAD)
organ donation over the last few years, probably as a
result of an increase in public awareness of the im-
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portance of organ donation,1, 2 However, this small
increase in organ supply has been superseded by the
big jump in the number of dialysis patients waiting
for kidney transplantation.1, 2 Under the circum-
stances, many have sought t ransplanta t ion in
mainland China, The use of such unconventional do-
nors organs has raised ethical problems, and is
associated with a higher rate of morbidity and mor-
tality.3, 4 In this review, the results of renal
transplantation in Queen Mary Hospital (QMH) are
studied, in order to assess the continuing role of LRD
kidney transplantation in Hong Kong.
Between 1983 and 1991, a total of 165 renal trans-
plants were performed by both the University and
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Fig. 1. Number of transplants per year at QMH.
Government surgical units in Queen Mary Hospital
(QMH). 159 cases were regularly followed up by the
university medical unit, QMH and were available for
analysis. Among them, two patients had two trans-
plants at QMH, and one patient had a previous
transplant in China. Recipients were selected on the
basis of age, duration of dialysis, blood group com-
patibility, negative cytotoxic cross-matching, and
HLA-A, B, DR matching.
Patients transplanted before 1984 were immuno-
suppressed with azathioprine and prednisolone. From
1984, patients who received HLA-nonidentical renal
allografts were treated with either (1) cyclosporin A
and prednisolone, or (2) cyclosporin A, azathioprine,
and prednisolone in a randomized trial. Patients who
received HLA-identical kidneys were given azathio-
prine and prednisolone only.
The patient and graft outcomes were analysed and
compared between the LRD and CAD groups. Stu-
dent's t test and Wilcoxon test were used respectively in
comparisons of waiting time for transplantation and the
graft function, as assessed by the latest follow-up serum
creatinine. The Chi-square test was used to analyse the
sex predominance, the surgical complications and in-
fection incidence. The cumulative graft survival was
compared by using the Mantel-Cox method. The level
of statistical significance was p < 0.05.
Results
Overall, 100 (63%) were LRD which included three
spouse donors and 59 (37%) were CAD (Fig. 1). Re-
cipients had a mean age of 34 years (range 11 to 57) in
the LRD group and a mean age of 38 years (range 20
to 56) in the CAD group. While the sex distribution in
CAD group was 31 males to 28 females, there was a
male predominance of 65 to 35 in the LRD group (p =
0.03). If one assumed that all patients who presented
with end stage renal failure and bilaterally contracted
but smooth kidneys as chronic glomerulonephritis,
the distribution was similar in both LRD and CAD
transplant recipients (65% and 68% respectively).
Glomerulonephritis on the whole accounted for 91.8%
of the primary renal diseases causing end stage renal
failure in our transplant recipients. Hypertension,
diabetes, reflux nephropathy and pyelonephritis ac-
counted for the remainder. Sixty-eight percent of
recipients were maintained on peritoneal dialysis, 30%
were on hemodialysis and 2% had been on both forms
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creatinine below 300 mmol/L. Graft function was
better in LRD compared to CAD recipients (p < 0.01)
(Table 2). There were no case of skin cancer and four
(2.5%) cases of malignancies, including a bladder
squamous cell carcinoma, a renal cell carcinoma of
the native kidney, an adenocarcinoma of stomach
and a hepatoma.
The patient survival was better among the LRD
group (7% vs 10.2%), but the difference failed to reach
statistical significance. Overall, six patients died of
infections, two of malignancies, two of cardiovascu-
lar events, one of graft failure and one of unknown
cause.
Table 2. Kidney function of surviving patients
Cr level
(mmol/L)
120
121-200
201-300
301-400
401-500
501-600
601-700
Total
LRT
*34 (40.5)
44 (52.4)
5 (5,9)
0 (0)
1 (1.2)
0 (0)
0 (0)
84 (100.0)
CAD
12 (28.5)
24 (57.1)
5 (11.9)
0 (0)
0 (0)
0 (0)
1 (2.4)
42 (100.0)
*Number affected (percentage)
Discussion
The present study has confirmed the findings from
overseas series that living related transplants are associ-
ated with a better allograft outcome when compared to
cadaveric transplant.5, 6 This is due to better matching of
major HLA and minor histocompatibility antigens and
a reduced incidence of delayed graft function in living
related transplantation due to shorter warm and cold
ischemic time and a lack of premorbid conditions in the
donors which may adversely affect renal function. The
latter is known to play an important role in improving
graft outcome because recent studies have shown that
living unrelated transplantation is associated with graft
outcome close to that of living related transplants and
superior to similarly matched cadaveric transplants.7, 12
Interestingly, we have found that living related
transplants are associated with a lower surgical com-
plication rate when compared to cadaveric tran-
splantation. Although few of these complications are
associated with graft loss, they do contribute to in-
creased morbidity in transplant recipients. The rea-
son for this difference could be related to the elective
nature of living related transplantation versus the
emergency setting of cadaveric renal transplantation.
As different groups of surgeons have been responsi-
ble for renal transplantation at our hospital over time
and the proportion of cadaveric versus living related
renal transplantation also varies over time, one could
not exclude the alternative possibility that the differ-
ence may reflect the relative experience and expertise
of different groups of surgeons.
The lack of cadaveric organ donors worldwide
and the difficulty in finding a living related donor
has prompted many transplant centres to consider
the use of organs from living unrelated donors. Re-
cent studies have shown that this form of
transplantation can be associated with a good graft
and patient survival.7, 12 While few will argue that
transplantation between spouses is acceptable because
the recipient and donor are emotionally related, di-
vided opinion exists for relationships other than
spouses. Most are concerned with the genuine inten-
tion of the donors and the likelihood of commercial
exploitation of both donors and recipients. In Hong
Kong, the general opinion is against the unrestricted
use of genetically or emotionally unrelated donors.
This is reflected in the introduction of the Human
Organ Transplant Bill which will shortly be enacted
to prohibit these types of transplants.
Few will argue that cadaveric renal transplanta-
tion is the preferred form of transplantation for
patients suffering from end stage renal failure be-
cause it does not involve subjecting another otherwise
normal individual to surgery. There is also the concern
that patients with a single kidney may suffer from the
long term consequences because of glomerular
hyperfiltration, an adaptive response of the single
kidney.9 We and others have examined the medical
and psychological well-being of renal donors and
found that the short-term and long-term risks to do-
nors are minimal.8, 10, 11 This together with the current
lack of cadaveric organ procurement in Hong Kong
fully justifies the continued use of living related do-
nor kidney for transplantation purpose.
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